Open access · CC-BY
via OpenAlex
Inflammaging: Experimental Insights and Translational Advances
European Journal of Immunology · 2026 · ▲ 6 citations
Dysbiosis
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Senolytics
Rapamycin / mTOR inhibition
Metformin
Human
Preclinical / animal
Review
Abstract
Inflammaging(definition), defined as the persistent, low-grade sterile inflammation accompanying aging, represents a central driver of age-related pathology, including cardiovascular dysfunction, neurodegeneration, metabolic disorders, and frailty. This review discusses the most recent advances in understanding its mechanistic basis, encompassing cellular senescence(definition), the senescence-associated secretory phenotype (SASP), mitochondrial dysfunction(definition), immune cell senescence, innate immune hyperactivation, defective inflammatory resolution, and nutrient-sensing dysregulation. Single-cell and spatial transcriptomics reveal tissue-specific and context-dependent patterns, highlighting the systemic complexity of inflammaging. Preclinical interventions demonstrate that inflammaging is modifiable through senolytics(definition), which selectively eliminate senescent cells, and senomorphics, which suppress SASP without inducing cell death. Metabolic modulators such as metformin and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) attenuate inflammatory signaling, while immune-directed therapies and microbiome-targeted interventions provide synergistic benefits through combinatorial approaches. Early-phase clinical trials in frail older adults show feasibility, safety, and preliminary efficacy, including reductions in circulating inflammatory markers, improved physical function, and enhanced immune responsiveness. Inflammaging trajectories are shaped by lifestyle, environmental exposures, and evolutionary factors, underscoring the need for personalized interventions. Remaining challenges include biomarker development, long-term safety evaluation, and heterogeneity across aging populations. Addressing these through interdisciplinary research supports a precision geroscience paradigm, where multimodal targeting of inflammaging can extend healthspan(definition) and reduce chronic disease burden.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/eji.70239
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Cossarizza, A. (2026). Inflammaging: Experimental Insights and Translational Advances. <em>European Journal of Immunology</em>. https://doi.org/10.1002/eji.70239
Vancouver
Cossarizza A. Inflammaging: Experimental Insights and Translational Advances. European Journal of Immunology. 2026. doi:10.1002/eji.70239.
BibTeX
@article{andrea2026Inflam,
title = {Inflammaging: Experimental Insights and Translational Advances},
author = {Andrea Cossarizza},
journal = {European Journal of Immunology},
year = {2026},
doi = {10.1002/eji.70239},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European journal of immunology 2026
Open access · OA
Inflammaging: Experimental Insights and Translational Advances.
Clinical and translational reports 2025
Open access · OA
Molecular and cellular drivers of inflammaging: Uncovering the diverse mechanisms and interventions of inflammaging
medtigo Journal of Medicine 2025
Open access · CC-BY
Senescence and Beyond: Exploring Senolytic Strategies for Chronic Disease
Frontiers in Aging 2026
Open access · CC-BY
Cellular senescence in age-related cardiovascular disease: past and future
Biogerontology 2026
Citation only
Senescent cells in systemic aging: SASP heterogeneity, immune escape, and endocrine modulation.
Geromedicine 2026
Open access · CC-BY